Skip to main content

Please wait ...

Phil Wolfson, MD


Phil Wolfson, MD, is president and CEO of the non-profit Ketamine Research Foundation and directs the training of KAP practitioners through The Ketamine Center. Phil’s book, The Ketamine Papers, is the seminal work in the burgeoning ketamine arena. He is principal investigator for the MAPS sponsored Phase 2, the FDA-approved 18-person study of MDMA-Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine-Assisted Psychotherapy.

Speaker Disclosures:
Financial: Philip Wolfson is the founder and CEO of The Ketamine Research Foundation. He has an ownership interest in Progressive Therapeutics, Inc. Dr. Wolfson will address off-label uses. He has no relevant financial relationships with ineligible organizations.
Non-financial: Philip Wolfson has no relevant non-financial relationship to disclose.

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and Other Mental Distress


Faculty:
Michael Mithoefer, MD |  Bessel van der Kolk, MD |  Richard C. Schwartz, PhD |  William Richards, Ph.D. |  Daniel McQueen, MA |  James W. Hopper, PhD |  Anne St. Goar, MD |  Elizabeth Call, PsyD |  ....
Duration:
6 Hours 28 Minutes
Format:
Audio and Video
Copyright:
May 29, 2019
Product Code:
POS052628
Media Type:
Digital Seminar - Also available: DVD
Price:
$219.99 - Standard

The Fantastic Effects of Ketamine Assisted Psychotherapy: A Revolution in Clinical Practice


Faculty:
Phil Wolfson, MD
Duration:
1 Hour
Format:
Audio and Video
Copyright:
Jul 28, 2022
Product Code:
NOS096253
Media Type:
Digital Seminar
Price:
$59.99 - Standard

Showing 1 to 4 of 4 entries